Your browser doesn't support javascript.
loading
SARS-CoV-2 Omicron variant emerged under immune selection.
Tan, Chee Wah; Chia, Wan Ni; Zhu, Feng; Young, Barnaby E; Chantasrisawad, Napaporn; Hwa, Shi-Hsia; Yeoh, Aileen Ying-Yan; Lim, Beng Lee; Yap, Wee Chee; Pada, Surinder Kaur M S; Tan, Seow Yen; Jantarabenjakul, Watsamon; Toh, Lim Kai; Chen, Shiwei; Zhang, Jinyan; Mah, Yun Yan; Chen, Vivian Chih-Wei; Chen, Mark I-C; Wacharapluesadee, Supaporn; Sigal, Alex; Putcharoen, Opass; Lye, David Chien; Wang, Lin-Fa.
Afiliação
  • Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. cheewah.tan@duke-nus.edu.sg.
  • Chia WN; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Zhu F; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Young BE; National Center of Infectious Diseases, Singapore, Singapore.
  • Chantasrisawad N; Tan Tock Seng Hospital, Singapore, Singapore.
  • Hwa SH; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Yeoh AY; Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Lim BL; Africa Health Research Institute, Durban, South Africa.
  • Yap WC; Division of Infection and Immunity, University College London, London, UK.
  • Pada SKMS; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Tan SY; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Jantarabenjakul W; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Toh LK; Ng Teng Fong General Hospital, Singapore, Singapore.
  • Chen S; National Center of Infectious Diseases, Singapore, Singapore.
  • Zhang J; Changi General Hospital, Singapore, Singapore.
  • Mah YY; Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Chen VC; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Chen MI; Doctors For Life Medical, Singapore, Singapore.
  • Wacharapluesadee S; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Sigal A; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Putcharoen O; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Lye DC; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Wang LF; National Center of Infectious Diseases, Singapore, Singapore.
Nat Microbiol ; 7(11): 1756-1761, 2022 11.
Article em En | MEDLINE | ID: mdl-36195753
The SARS-CoV-2 Omicron variant (B.1.1.529 lineage) escapes antibodies that neutralize the ancestral virus. We tested human serum panels from participants with differing infection and vaccination status using a multiplex surrogate virus neutralization assay targeting 20 sarbecoviruses. We found that bat and pangolin sarbecoviruses showed significantly less neutralization escape than the Omicron variant. We propose that SARS-CoV-2 variants have emerged under immune selection pressure and are evolving differently from animal sarbecoviruses.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article